Clinical Trial Update: Study Of Nintedanib Compared To Chemotherapy in Patients With Recurrent Clear Cell Carcinoma Of The Ovary Or Endometrium [Phase 2]

View source ↗

Summary

A Phase 2 trial is comparing nintedanib against chemotherapy in patients with recurrent ovarian clear cell carcinoma or recurrent endometrial clear cell carcino…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Clear Cell Carcinoma
• Ovarian Clear Cell Carcinoma

Drugs mentioned

• Chemotherapy (chemotherapy)
• Nintedanib (nintedanib)

Snippet

Sponsor: NHS Greater Glasgow and Clyde | Conditions: Ovarian Clear Cell Carcinoma, Endometrial Clear Cell Carcinoma | Phase 2 | Status: UNKNOWN